Peran Neuregulin-1 (NRG-1), Acidic Fibroblast Growth Factor (FGF), dan Vascular Endothelial Growth Factor (VEGF) pada Sel Perisit sebagai Inovasi Terbaru Penanganan Infark Miokard akibat Aterosklerosis
Authors
-
Ignatius Ivan
Atma Jaya University
-
Nicolas Daniel Widjanarko
Atma Jaya Catholic University of Indonesia
-
Harvey Sudharta
Atma Jaya Catholic University of Indonesia
-
Maureen Miracle Stella
Atma Jaya Catholic University of Indonesia
http://orcid.org/0000-0003-2932-3498
-
Kevin Tandarto
Atma Jaya Catholic University of Indonesia
-
Mariani Santosa
Atma Jaya Catholic University of Indonesia
Keywords:
sitokin, faktor pertumbuhan, sel punca, perisit, infark miokardAbstract
Infark miokard telah mengakibatkan 17 juta kematian di seluruh dunia pada tahun 2005. Hal ini terutama disebabkan karena terjadinya nekrosis sel miokard akibat iskemia jangka panjang. Agen trombolitik tidak memiliki pengaruh dalam meregenerasi pembuluh darah yang pecah. Oleh karena itu, banyak sel induk pembuluh darah, terutama perisit, dibawa untuk merangsang pembangunan, pematangan, rekonstruksi, dan mempertahankan permeabilitas pembuluh baru. Di sisi lain, beberapa faktor pertumbuhan seperti Neuregulin-1 (NRG-1), Acidic Fibroblas Growth Factor (FGF), dan Vascular Endothelial Growth Factor (VEGF) juga memainkan peran dalam angiogenesis yang merupakan jalur utama proses penyembuhan akibat iskemia. Tujuan dari kajian ilmiah ini adalah untuk menjelaskan peran perisit yang distimulasi oleh leptin, bersama dengan beberapa faktor pertumbuhan yang diselubungi oleh mikropartikel sebagai terapi baru infark miokard yang terutama disebabkan oleh aterosklerosis. Hasil kajian menunjukkan bahwa perisit memiliki kemampuan untuk berdiferensiasi menjadi sel otot polos, sel saraf, dan sel endotel. Proses ini dipengaruhi oleh leptin dan juga beberapa faktor pertumbuhan yang diselubungi oleh mikropartikel untuk meningkatkan stabilitas dan imunitas terhadap makrofag. Terapi sel punca dengan menggunakan perisit yang distimulasi oleh leptin dan faktor pertumbuhan yang diselubungi oleh mikropartikel dapat menjadi metode pengobatan infark miokard yang menjanjikan di masa depan.
References
Ae B 2016. ‘The Clinical Utility of Circulating Microparticles Measurement in Heart Failure Patients’, J Vasc Med Surg, 6,pp.1–11.
Avolio E et al., 2015. ‘Combined Intramyocardial Delivery of Human Pericytes and Cardiac Stem Cells Additively Improves the Healing of Mouse Infarcted Hearts Through Stimulation of Vascular and Muscular RepairNovelty and Significance’, Circ Res, 116(10),pp.e81–94.
Avolio E et al., 2015. ‘Expansion and Characterization of Neonatal Cardiac Pericytes Provides a Novel Cellular Option for Tissue Engineering in Congenital Heart Disease’, J Am Heart Assoc, 4(6),e002043.
Alvarez-Martins I et al.,2016. ‘The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment’, Pflugers Arch, 468,pp.919–32.
Birbrair A 2014. ‘Pericyte subtypes at the intersection between tissue regeneration and pathology [Ph.D.],’ [United States -- North Carolina]: Wake Forest University.
Birbrair A et al., 2013. ‘Role of pericytes in skeletal muscle regeneration and fat accumulation’, Stem Cells Dev, 22(16),pp.2298–314.
Bobryshev Yv et al., 2015. ‘Vascular stem/progenitor cells: current status of the problem’, Cell Tissue Res, 362(1),pp.1–7.
Chatzizisis YS et al., 2007. ‘Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior’, J Am Coll Cardiol, 49(25),pp.2379–93.
Corselli M et al., 2011. ‘The Tunica Adventitia of Human Arteries and Veins As a Source of Mesenchymal Stem Cells’, Stem Cells Dev, 21(8),pp.1299–308.
Dellavalle A et al., 2011. ‘Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells’, Nat Commun, 2,pp.499.
Díaz-Herráez P et al., 2017. ‘Transplantation of adipose-derived stem cells combined with neuregulin-microparticles promotes efficient cardiac repair in a rat myocardial infarction model’, J Control Release Off J Control Release Soc, 10,pp.249:23–31.
Garbayo E et al., 2016. ‘Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion’, Sci Rep, 6, srep25932.
Geng Y-J et al., 2006. ‘Vascular stem cells: a new concept in the pathogenesis of atherosclerosis and interventions for coronary heart disease’, Future Cardiol, 2(5),pp.585–92.
Heusch G et al., 2014. ‘Cardiovascular remodelling in coronary artery disease and heart failure’, Lancet Lond Engl, 383(9932),pp.1933–43.
Katare R et al., 2011. ‘Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132Novelty and Significance’, Circ Res, 109(8),pp.894–906.
Karal-Y?lmaz O et al., 2011. ‘Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique’, J Microencapsul, 28(1),pp.46–54.
Kawabe J-I and Hasebe N 2014. ‘Role of the vasa vasorum and vascular resident stem cells in atherosclerosis’, BioMed Res Int, ,701571.
Kelly-Goss MR et al., 2014. ‘Sweat RS, Stapor PC, Peirce SM, Murfee WL. Targeting pericytes for angiogenic therapies’, Microcirc N Y N 1994, 21(4),pp.345–57.
Kinard LA et al., 2012. ‘Synthesis of oligo(poly(ethylene glycol) fumarate)’, Nat Protoc, 7(6),pp.1219–27.
Kumar A and Cannon CP 2009. ‘Acute Coronary Syndromes: Diagnosis and Management, Part I’, Mayo Clin Proc, 84(10),pp.917–38.
Li N et al., 2014. ‘Heart regeneration, stem cells, and cytokines’, Regen Med Res, 2(1).
Mendis S et al., 2011. 'World Health Organization definition of myocardial infarction: 2008–09 revision', Int J Epidemiol, 40(1),pp.139–46.
Mitchell A et al., 2015. 'Vascular injury and repair: a potential target for cell therapies', Future Cardiol, 11(1),pp.45–60.
Psaltis PJ and Simari RD 2015. 'Vascular Wall Progenitor Cells in Health and Disease', Circ Res, 116(8),pp.1392–412.
Rebouças J de S et al., 2016. 'Cardiac Regeneration using Growth Factors: Advances and Challenges', Arq Bras Cardiol, 107(3),pp.271–5.
Riu F et al., 2017. 'The adipokine leptin modulates adventitial pericyte functions by autocrine and paracrine signalling', Sci Rep, 1,pp. 7.
Saleem S et al., 2016. 'Post thrombolytic resolution of ST elevation in STEMI patients', Pak J Med Sci, 32(1),pp.201–5.
Simón-Yarza T et al., 2013. 'PEGylated-PLGA microparticles containing VEGF for long term drug delivery', Int J Pharm, 440(1),pp.13–8.
Tang Z et al., 2012. 'Differentiation of multipotent vascular stem cells contributes to vascular diseases', Nat Commun, 3,pp.875.
Tahergorabi Z and Khazaei M 2015. 'Leptin and its cardiovascular effects: Focus on angiogenesis', Adv Biomed Res, 4,pp.79.
Vassiliadis E et al., 2012. 'Novel cardiac-specific biomarkers and the cardiovascular continuum', Biomark Insights, 7,pp.45–57.
Xin M et al., 2013. 'Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair', Nat Rev Mol Cell Biol 14,pp. 529-541, Vol. 14. 2013.
